Prostatic Hypertrophy, Benign Unknown Status Phase Trials for Alfuzosin (DB00346)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00256399Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)Treatment